Treating Major Depression With Yoga Mono-therapy

Status Not yet recruiting

Clinical Trial Summary

The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to a an education control intervention on holistic healthcare.

Clinical Trial Description

Consenting participants will be randomized equally to one of three in-person group interventions for 12 weeks: Standard yoga practice, Ayurvedic yoga practice, or educational attention-control modules. The primary outcome is depression severity, measured by Beck Depression Inventory-II (BDI) scores. Secondary outcomes include perceived stress, measured by Perceived Stress Scale (PSS) scores, and several biomarker assays associated with depression severity: methylation of the GrimAge epigenetic clock, nuclear factor kappa-B (NF-κB) transcription, leucocyte telomere length, and serum levels of telomerase, interleukin-6 (IL-6) and brain-derived neurotropic factor (BDNF). Blinded assessors will conduct all outcome analyses at 12 weeks. The primary analysis will test whether the yoga groups combined achieve statistically greater reduction in BDI scores compared to the control group. Secondary analyses will test whether the yoga groups combined, compared to the control group, demonstrate statistically greater: reduction in PSS scores, reduction in methylation of the GrimAge epigenetic clock, reduction in NF-κB transcription, reduction in serum IL-6, increase in leucocyte telomere length, increase in serum telomerase, and increase in serum BDNF. In sub-analyses, we will assess whether Ayurvedic yoga participants, compared to Standard yoga participants, demonstrate statistically significant improvements in BDI scores, PSS scores, and depression biomarker assays over the 12-week intervention period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06091527
Study type	Interventional
Source	University of California, San Francisco
Contact	Sudha Prathikanti, MD
Phone	415-516-3867
Email	sudha.prathikanti@ucsf.edu
Status	Not yet recruiting
Phase	Phase 2
Start date	November 2023
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05868135` - Effects and Cost-effectiveness of e-Meistring - a Guided Internet-delivered Psychological Treatment
Not yet recruiting	`NCT05539495` - Exercise Recovery From Persistent Depression: A Thematic Analysis
Completed	`NCT04192721` - Cognitive Behavioral Therapy-Based Group Counseling	N/A
Completed	`NCT06072209` - Long-term Effects ReSet Your Mind - Mechanisms	N/A
Completed	`NCT05402150` - An Online Intervention Targeting Depression and Low Reward Sensitivity	N/A
Completed	`NCT04318236` - Factorial Trial Investigating Outcome and Adherence Relevant Factors in an Online Self-help Intervention for Depression	N/A
Recruiting	`NCT06374056` - Kintsugi Voice Device Pilot Study
Recruiting	`NCT04211467` - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Depression
Recruiting	`NCT06273995` - Telehealth Behavioral Activation for Teens	N/A
Completed	`NCT05025904` - Real-time fMRI Neurofeedback for Mild/Moderate Depression	N/A
Terminated	`NCT04948996` - Treatment of Depression Using a Mobile Application in the Dominican Republic	N/A
Recruiting	`NCT06014125` - Paramedical Tele-education on Moderate Depressive Episodes	N/A
Completed	`NCT03405493` - Sleep, Wake and Light Therapy for Depression	N/A
Recruiting	`NCT05267340` - Neural Mechanisms of Meditation Training in Healthy and Depressed Adolescents: An MRI Connectome Study PART 2	N/A
Recruiting	`NCT04404309` - Outcomes Associated With Suicidality in Inpatients With Symptoms of Depression (OASIS-D)
Recruiting	`NCT05788198` - Integrated Depression Care	N/A
Recruiting	`NCT06456931` - A Pilot Study Comparing the Efficacy of Traditional Buddhist Mindfulness Training Versus Secular Mindfulness-based Cognitive Therapy for Patients Having Residual Depressive Symptoms	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.